Dark
Light
System
Institutional Investment Manager
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB (CIK: 0001599882), located at Strandvagen 5a, Stockholm. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q3)
Portfolio Summary: 107 holdings with a total value of $629,612,212.
#
Name
Shares
Value ($)
%
Options
Notes
1 THRESHOLD PHARMACEUTICAL INC 201,537 136,541 0.02%
2 FORD MTR CO DEL 14,611 176,355 0.03%
3 JPMORGAN CHASE & CO 2,688 178,994 0.03%
4 MICROSOFT CORP 3,140 180,864 0.03%
5 INTERNATIONAL BUSINESS MACHS 1,143 181,566 0.03%
6 EXXON MOBIL CORP 2,102 183,463 0.03%
7 HALLIBURTON CO 4,231 189,887 0.03%
8 GLAUKOS CORP 5,100 192,474 0.03%
9 CATERPILLAR INC 2,178 193,341 0.03%
10 QUALCOMM INC 2,869 196,526 0.03%
11 WELLS FARGO & CO NEW 4,522 200,234 0.03%
12 OCULAR THERAPEUTIX INC 40,000 274,800 0.04%
13 CONCERT PHARMACEUTICALS INCORPORATED 30,099 304,301 0.05%
14 MIRATI THERAPEUTICS INC COM 50,000 330,500 0.05%
15 OREXIGEN THERAPEUTICS INC 120,000 398,400 0.06%
16 MEDNAX INC 9,000 596,250 0.09%
17 Catabasis Pharmaceuticals Inc 100,000 616,000 0.10%
18 ADVERUM BIOTECHNOLOGIES INC 154,006 632,965 0.10%
19 ANTHERA PHARMACEUTICALS I 300,000 945,000 0.15%
20 REGULUS THERAPEUTICS INC COM 300,000 990,000 0.16%
21 TETRAPHASE PHARMACEUTICALS INC COM 300,000 1,149,000 0.18%
22 VALEANT PHARMACEUTICALS INTL 50,000 1,227,500 0.19%
23 ACADIA PHARMACEUTICALS INC COM 50,000 1,590,500 0.25%
24 INTERCEPT PHARMACEUTICALS INCORPORATED 10,000 1,645,900 0.26%
25 JOHNSON & JOHNSON 15,000 1,771,950 0.28%
26 TANDEM DIABETES CARE INC COM 234,000 1,792,440 0.28%
27 Esperion Therapeutics Inc 130,000 1,800,500 0.29%
28 NEUROCRINE BIOSCIE COM USD0.001 40,000 2,025,600 0.32%
29 INTRA-CELLULAR THERAPIES INC 135,000 2,057,400 0.33%
30 ADAMAS PHARMACEUTICALS INC 130,000 2,133,300 0.34%
31 FIBROGEN INC 104,000 2,152,800 0.34%
32 ACHILLION PHARMACEUTICALS IN 266,000 2,154,600 0.34%
33 TESARO INCORPORATED 21,500 2,155,160 0.34%
34 RITE AID CORP 300,000 2,307,000 0.37%
35 INSULET CORPORATION 57,000 2,333,580 0.37%
36 KERYX BIOPHARMACEUTICALS INCORPORATED 500,111 2,655,589 0.42%
37 NEURODERM LTD 144,546 2,672,656 0.42%
38 PORTOLA PHARMACEUTICALS INC 120,805 2,743,482 0.44%
39 HALOZYME THERAPEUTICS INC 250,000 3,020,000 0.48%
40 CHIMERIX INC 550,000 3,047,000 0.48%
41 DYNAVAX TECHNOLOGIES CORP 300,000 3,147,000 0.50%
42 PERRIGO CO PLC 35,000 3,231,550 0.51%
43 REVANCE THERAPEUTICS INC COM 210,000 3,404,100 0.54%
44 COHERUS BIOSCIENCES INC COM 131,357 3,517,740 0.56%
45 COOPER COS INC 20,000 3,585,200 0.57%
46 NXSTAGE MED INC COM 145,300 3,631,047 0.58%
47 DAVITA INC 55,000 3,633,850 0.58%
48 UNIVERSAL HLTH SVCS INC 30,000 3,696,600 0.59%
49 ARRAY BIOPHARMA INC 550,000 3,712,500 0.59%
50 CEMPRA INC 161,000 3,896,200 0.62%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-007347, filed 2016.11.08).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.